Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
Wang Xiaodong (CIK 1662982) reported 42 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-09-10). Recent activity: Sell ONC (1,181 shares), Sell ONC (2,841 shares), Sell ONC (1,517 shares), Sell ONC (1,721 shares), Buy ONC (31,027 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-10 | BeOne Medicines Ltd. (ONC) | Director | Sell | 1,181 | $407,897 |
| 2026-09-10 | BeOne Medicines Ltd. (ONC) | Director | Sell | 2,841 | $983,433 |
| 2026-09-10 | BeOne Medicines Ltd. (ONC) | Director | Sell | 1,517 | $526,993 |
| 2026-09-10 | BeOne Medicines Ltd. (ONC) | Director | Sell | 1,721 | $598,930 |
| 2026-09-10 | BeOne Medicines Ltd. (ONC) | Director | Buy | 31,027 | $1.1M |
| 2026-09-10 | BeOne Medicines Ltd. (ONC) | Director | Sell | 7,492 | $2.6M |
| 2026-09-10 | BeOne Medicines Ltd. (ONC) | Director | Sell | 10,688 | $3.7M |
| 2026-09-10 | BeOne Medicines Ltd. (ONC) | Director | Sell | 6,569 | $2.3M |
| 2026-09-10 | BeOne Medicines Ltd. (ONC) | Director | Sell | 6,278 | $2.2M |
| 2026-06-15 | BeOne Medicines Ltd. (ONC) | Director | Buy | 99,892 | $0 |
| 2025-11-12 | BeOne Medicines Ltd. (ONC) | Director | Sell | 424,073 | $0 |
| 2025-09-11 | BeOne Medicines Ltd. (ONC) | Director | Sell | 148,096 | $0 |
| 2025-06-25 | BeOne Medicines Ltd. (ONC) | Director | Sell | 300 | $79,050 |
| 2025-06-25 | BeOne Medicines Ltd. (ONC) | Director | Sell | 1,100 | $291,885 |
| 2025-06-25 | BeOne Medicines Ltd. (ONC) | Director | Sell | 507 | $135,151 |
| 2025-06-25 | BeOne Medicines Ltd. (ONC) | Director | Sell | 100 | $26,781 |
| 2025-06-12 | BeOne Medicines Ltd. (ONC) | Director | Buy | 98,696 | $0 |
| 2025-06-12 | BeOne Medicines Ltd. (ONC) | Director | Buy | 41,760 | $271,440 |
| 2025-06-12 | BeOne Medicines Ltd. (ONC) | Director | Sell | 2,901 | $757,741 |
| 2025-06-12 | BeOne Medicines Ltd. (ONC) | Director | Sell | 15,878 | $4.2M |
| 2025-06-12 | BeOne Medicines Ltd. (ONC) | Director | Sell | 16,094 | $4.2M |
| 2025-06-12 | BeOne Medicines Ltd. (ONC) | Director | Sell | 6,787 | $1.8M |
| 2025-06-12 | BeOne Medicines Ltd. (ONC) | Director | Sell | 100 | $26,485 |
| 2025-05-15 | BeiGene, Ltd. (BGNE) | Director | Buy | 41,760 | $271,440 |
| 2025-05-15 | BeiGene, Ltd. (BGNE) | Director | Sell | 10,221 | $2.3M |
Source: SEC Form 4 filings · as of 2026-09-10